A significantly increased risk of breast, prostate, cervical, and non-melanoma skin cancer was recently reported in first-degree relatives of early-onset breast cancer patients from Sweden that tested negative for BRCA1 and BRCA2 mutations [47]. Here, BRCA2 is linked to breast carcinoma.